Management Strategies of Breast Cancer Patients with <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Germline Variants.

Publication Year: 2022

DOI:
10.2147/OTT.S369844

PMCID:
PMC9343017

PMID:
35923470

Journal Information

Full Title: Onco Targets Ther

Abbreviation: Onco Targets Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure SE has no conflict of interest to report, HA received institutional research grant from Pfizer."

Evidence found in paper:

"Disclosure: SE has no conflict of interest to report, HA received institutional research grant from Pfizer."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025